Women's Health
From the Journals
AF risk is elevated after early-stage breast cancer diagnosis
The rate of AF was elevated in the first year post diagnosis and after 5 years post diagnosis, with greater elevation for women who received...
From the Journals
USPSTF: Screening pregnant women for asymptomatic bacteriuria cuts pyelonephritis risk
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
Conference Coverage
Vitamin D does not improve bone density, structure in healthy patients
ORLANDO – Daily use for 2 years did not affect areal BMD in the whole body, femoral neck, total hip, or spine, or...
Conference Coverage
Closure of women’s health clinics may negatively impact cervical cancer outcomes
Mortality risk among women with cervical cancer was 36% higher in states that had a decreased number of women’s clinics.
Conference Coverage
Remember that preeclampsia has a ‘fourth trimester’
Delivering the baby doesn’t always cure the hypertension.
From the Journals
Drug doses for heart failure could possibly be halved for women
Guidelines
Try testosterone for some women with sexual dysfunction, but not others
Evidence does not support testosterone use for other conditions, and concentrations should mirror premenopausal physiological conditions.
From the Journals
Zoledronate maintains bone loss after denosumab discontinuation
The results suggest that, after achieving nonosteoporotic BMD with denosumab, a single intravenous infusion of zoledronate given 6 months after...
From the Journals
High-dose vitamin D for bone health may do more harm than good
A randomized trial showed an inverse dose-response relationship between high-dose vitamin D supplementation and bone quality in healthy adults.
From the Journals
FRAX with BMD may not be accurate for women with diabetes
Both major osteoporotic fracture and hip fracture are underestimated by FRAX with BMD in women with diabetes.
From the Journals
USPSTF expands BRCA1/2 testing recommendations
Personal cancer history, ancestry now key factors in decision to assess, counsel, and test for potentially harmful mutations in BRCA1/2 genes.